Close Menu

NEW YORK (GenomeWeb) – As the Dow Jones Industrial Average saw its worst December since the Great Depression and its worst year in a decade, the GenomeWeb Index ended 2018 in a crater, dropping more than 11 percent.

The index erased its 4 percent gain from November, and underperformed both the Dow and the Nasdaq, which lost 9 percent and 10 percent in December, respectively. It performed on par with the Nasdaq Biotechnology Index, which also lost 11 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.